Kari Heimholt

Kari Heimholt is a highly experienced professional in the pharmaceutical and clinical research fields, currently serving as the Leader of the Clinical Trials Department at Sykehusapotekene HF in Oslo since March 2021. In addition to this role, Kari is the National Coordinator for IMPRESS-Norway, a clinical trial aimed at enhancing public cancer care through the integration of precision medicine. Kari's extensive background includes over two decades at Pfizer in various leadership roles focused on compliance and quality management across Norway, Sweden, and Finland. Prior experience includes serving as Regulatory Affairs Manager at Novo Nordisk. Kari holds a Master of Science in Pharmacy (Cand.pharm.) from the University of Oslo, obtained in 1991.